Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia.
- Authors
- O'Connor, J A; Hemby, S E
- Year
- 2007
- Journal
- Schizophrenia research
- PMID
- 17942280
- DOI
- 10.1016/j.schres.2007.09.022
- PMCID
- PMC3255089
The functional integrity of the dorsolateral prefrontal cortex (DLPFC) is altered in schizophrenia leading to profound deficits in working memory and cognition. Growing evidence indicates that dysregulation of glutamate signaling may be a significant contributor to the pathophysiology mediating these effects; however, the contribution of NMDA and AMPA receptors in the mediation of this deficit remains unclear. The equivocality of data regarding ionotropic glutamate receptor alterations of subunit expression in the DLPFC of schizophrenics is likely reflective of subtle alterations in the cellular and molecular composition of specific neuronal populations within the region. Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC. Comparisons were made between individuals diagnosed with schizophrenia, bipolar disorder, major depressive disorder and controls (n=15/group). All subunits were expressed at detectable levels in both cell populations for all diseases as well as for the control group. Interestingly, GRIA1 mRNA was significantly increased in both cell types in the schizophrenia group compare to controls, while similar trends were observed in major depressive disorder (Layers II/III and V) and bipolar disorder (Layer V). These data suggest that increased GRIA1 subunit expression may contribute to schizophrenia pathology.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | 2012 | 22064162 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Altered Molecular Composition of a Specific Subset of Prefrontal Cortical Excitatory Synapses in Schizophrenia. | Lorincz A et al. | β | 2025 | β |
| Chronic haloperidol administration downregulates select BDNF transcript and protein levels in the dorsolateral prefrontal cortex of rhesus monkeys. | Hemby SE et al. | β | 2023 | β |
| Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking. | He JG et al. | β | 2023 | β |
| Identification of rare missense mutations in the glutamate ionotropic receptor AMPA type subunit genes in schizophrenia. | Lin KH et al. | β | 2023 | β |
| Integrating spatial and single-nucleus transcriptomic data elucidates microglial-specific responses in female cynomolgus macaques with depressive-like behaviors. | Wu J et al. | β | 2023 | β |
| AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. | Yonezawa K et al. | β | 2022 | β |
| Maternal immune activation induces methylation changes in schizophrenia genes. | Johnson T et al. | β | 2022 | β |
| Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners. | Levy AM et al. | β | 2022 | β |
| Profiling cell-type specific gene expression in post-mortem human brain samples through laser capture microdissection. | Almeida D et al. | β | 2022 | β |
| Deciphering the Forebrain Disorder in a Chicken Model of Cerebral Hernia. | Tao Y et al. | β | 2020 | β |
| Characterization of the Hippocampal Neuroimmune Response to Binge-Like Ethanol Consumption in the Drinking in the Dark Model. | Grifasi IR et al. | β | 2019 | β |
| Evidence for cerebello-thalamo-cortical hyperconnectivity as a heritable trait for schizophrenia. | Cao H et al. | β | 2019 | β |
| A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders. | de Sena Cortabitarte A et al. | β | 2018 | β |
| Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex. | Prini P et al. | β | 2018 | β |
| Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis. | Iamjan SA et al. | β | 2018 | β |
| Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia. | Kimoto S et al. | β | 2016 | β |
| Sex differences in glutamate receptor gene expression in major depression and suicide. | Gray AL et al. | β | 2015 | β |
| The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. | Hu W et al. | β | 2015 | β |
| Association analysis of the GRM8 gene with schizophrenia in the Uygur Chinese population. | Zhang L et al. | β | 2014 | β |
| Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network. | Savitz JB et al. | β | 2014 | β |
| Structural basis of PI(4,5)P2-dependent regulation of GluA1 by phosphatidylinositol-5-phosphate 4-kinase, type II, alpha (PIP5K2A). | Seebohm G et al. | β | 2014 | β |
| The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. | Iasevoli F et al. | β | 2014 | β |
| The role of NMDA receptors in the pathophysiology and treatment of mood disorders. | Ghasemi M et al. | β | 2014 | β |
| Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons. | Wang MJ et al. | β | 2013 | β |
| Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. | Chiesa A et al. | β | 2012 | β |
| Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. | Ginsberg SD et al. | β | 2012 | β |
| Genetic variants of GRIA1 are associated with susceptibility to schizophrenia in Korean population. | Kang WS et al. | β | 2012 | β |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | β | 2012 | β |
| The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring. | Fatemi SH et al. | β | 2012 | β |
| Altered levels of glutamatergic receptors and Na+/K+ ATPase-Ξ±1 in the prefrontal cortex of subjects with schizophrenia. | Corti C et al. | β | 2011 | β |
| Analyzing schizophrenia by DNA microarrays. | HorvΓ‘th S et al. | β | 2011 | β |
| Neuroimaging and neuropathological findings in bipolar disorder. | Savitz J et al. | β | 2011 | β |
| Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. | Cherlyn SY et al. | β | 2010 | β |
| The cerebral cortex overlying periventricular leukomalacia: analysis of pyramidal neurons. | Andiman SE et al. | β | 2010 | β |
| Expression profiles of schizophrenia susceptibility genes during human prefrontal cortical development. | Choi KH et al. | β | 2009 | β |
| GLT-1 upregulation impairs prepulse inhibition of the startle reflex in adult rats. | Bellesi M et al. | β | 2009 | β |
| Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse. | Kerner B | β | 2009 | β |
| NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique. | Xi D et al. | β | 2009 | β |
| The cerebral microvasculature in schizophrenia: a laser capture microdissection study. | Harris LW et al. | β | 2008 | β |